Novavax to Report Q3 Earnings: Here's What to Expect
On NVAX's third-quarter earnings call, investors will likely seek updates on management???s ongoing discussions with the FDA ...
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Indiatimes27m
US FDA lifts clinical hold on Novavax's combo Covid-flu shot
The person was administered the vaccine in January last year as part of a mid-stage study. Novavax said on Monday it had ...
Seeking Alpha3h
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza Combination ...
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
Novavax, Inc.: U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...
Daily5h
Moderna bags Health Canada nod for RSV vaccine for adults aged 60 years and older
Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for ...
Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury
RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus.
Indiatimes16h
WORLD NEWS
Upon a potential return to the White House, Donald Trump has outlined a series of immediate actions for his first day and second term. These include dismissing legal cases against him, enacting ...